LC Unit 2 Flashcards
tissue, cellular, and functional organization of breast tissue in non-lactating state
breast is composed of glandular lobes
- composed of multiple lobules containing alveoli (milk producing units) that are connected by ductal network that empties into a single milk duct
- milk ducts from multiple lobes feed into the nipple
alveolar structures:
- composed of myoepithelial and secretory epithelial cells
- at tips of ducts
- responsible for synthesis/secretion of like
- lobuloaveolar unit also called terminal ductal lobular unit (TDLU)
breast is mainly composed of ligaments and inter glandular fat
- glandular components are very proximal to nipple and don’t radiate out very far
- glands of ducts are superficial and easily damaged, esp during surgery
- number of ducts ranges from 4-14 ducts; avg 9
relative distribution of breast tissue in lactating state vs non-lactating
lactating breast:
glandular component 64%
intraglandular fat 6%
non lactating breast:
glandular component 20%
intraglandular fat 49%
stages of breast development and key hormones
embryogenesis:
- establishment of rudimentary gland
- ectoderm invades mesenchyme; develops secondary buds and a fat pad
hormonal control of nipple morphogenesis:
PTH related protein PTHrP
-interacts w/ mesenchymal cells to induce differentiation into fat pad, which is required for further elaboration of duct and formation of mammary gland
–absence of PTHrP: Blomstrands achondroplasia (amastia)
neonatal breast morphology: maternal hormone influence
- presence of secretory product in ducts (elevated PRL and low Progesterone at parturition can induce temporary milk sectretion- witches milk)
- simple ductal network ending with TEB structures
- branching ductal network with lobules (progesterone receptors present for up to 3mo; thought to be driven by temporary GnRH-driven spike in progesterone to stimulate branching and lobule formation)
Puberty:
-elaboration/growth of ducts and alveoli
-macroscopic development due to increase in fat accumulation in mammary adipose tissue
-driven by estrogen and progesterone
-associated with Tanner scale, but not a hard indicator of functional development
-menstrual cycle drives developmental changes
(increase in estrogen in combo w/ GH is primary driver of ductal elongation by increasing IGF-1 production by stromal cells; progesterone secretion during luteal phase acts to elaborate the side branches of the ducts and lobuloaveolar TDLU development; these 2 together are responsible for arborization; no further elaboration of ducts at end of puberty because there’s no more GH, even though there’s estrogen present)
changes that occur during pregnancy:
- glandular morphogenesis
- secretory differentiation
- –lactogenesis-1 initiation of milk protein expression and development of secretory capacity
- –lactogenesis-2 copious milk production
-features: increased lobules, differentiation of alveolar cells, inhibition of milk secretion
- hormones during pregnancy:
- —ovaries and placenta: estrogen, progesterone, placental lactogen
- —pituitary: prolactin
- progesterone is required for alveolar formation during pregnancy
- both progesterone and PRL are required for full alveolar maturation
- milk protein expression is initiated during pregnancy by PRL or placental lactogen but milk secretion is held in check by Progesterone levels
hormonal basis of breast abnormalities in males
ratio of T/estrogen during puberty, esp initially, can cause temporary gynecomastia
–disappears as M gains more T
neural and hormonal mechanisms that regulate lactation
initiation of lactation:
- milk secretion initiated by the fall in progesterone at parturition (removal of placenta)
- elevated prolactin levels maintain synthesis and secretion of milk
lactation requires PRL and oxytocin-regulated by neuroendocrine feedback
2 components of lactation:
- milk secretion (prolactin and milk removal)
- milk ejection (oxytocin and suckling; requires alveoli to be squeezed)
Prolactin:
- is released in pulses
- pulse size/frequency are regulated by suckling stimulus
- suckling is required to maintain PRL levels
- failure to initiate breastfeeding shortly after parturition leads to loss of PRL and impaired ability to maintain lactation (problem w/ preterm infants)
Oxytocin:
- required for milk ejection
- stimulates contraction of myoepithelial cells that form basket-like network around alveoli
feedback loop that controls lactation
Anterior pituitary:
- releases prolactin
- causes milk secretion
baby:
- Dopamine inhibits prolactin release
- suckling inhibits dopamine release from posterior pituitary
- suckling frees up the release of prolactin
Neuroendocrine reflex:
oxytocin:
-produced/released by posterior pituitary
-suckling, conditioning can stimulate oxytocin
-stress can inhibit oxytocin
sources and actions of specific hormones that control lactation
prolactin is required for milk synthesis and secretion
oxytocin is required for milk ejection
factors that influence neuroendocrine reflex can negatively impact lactation
cellular pathways involved in milk secretion
water and proteins are released via classical secretion proteins
cytoplasmic lipid droplets are enveloped by membrane and released
during lactation- transepithelial tight junctions are closed
prior/shortly after lactation- the junctions are open and allows circulatory system to get into milk
-sIgA, lactoferrin (antiinflammatory/immunity agensts) are elevated in milk
progression of lactation
-physiological changes and composition of milk
time course of lactogenesis in women:
- milk volume increase
- tight junction closure
- transcytosis of sIgA
- coordinated increase in secretory activity
human milk (vs bovine): -high amounts of oligosaccharides (prevent infantile infection)
individual milk volumes vary considerably but the timing of milk production is very similar
- timing is related to closure of tight junctions
- immunity portion w/ open tight junctions (sIgA secretion and leukocytes)
- when tight junctures finally close by ~3days postpartum, the milk volume increases substantially and transitions to nutrition (vs immunity)
physiological factors that affect lactation
Factors affecting lactation:
- anxiety/stress
- delayed lactation initiation
- pituitary disorders or damage
- excessive weight/obesity (inhibit PRL secretion)
removal of milk is required to maintain glandular integrity
a prior pregnancy primes the breast for milk production
nutritional composition of breast milk
breast milk:
- dynamic fluid secreted from mammary glands
- changes throughout the day
colostrum milk:
- yellow in color
- high in IgA and lactoferrin (anti-infection properties)
- higher protein, lower fat and lactose
- facilitates: est of lactobacillus and passage of meconium
transitional milk:
- 2-14 days
- imunoglobulins and protein decrease
- lactose and fat increase
- increase in calories
- vitamin changes
mature milk:
- water (maintains infant hydration; largest constituent)
- lipids (50% of calories; variety; varies during feeding)
- proteins (WHEY and casein, lactoferrin- inhibits growth of Fe-dependent bacteria in GI tract)
- immunoglobulin s(sIgA- offers mucosal protection)
- other antimicrobial factors
- Carbs (lactose mainly)
- trace elements (Fe, Zn)
- Vitamins (Vit D- inadequate due to lack of infant production from sunlight)
- foremilk: milk at beginning of feeding (blue-ish)
- hindmilk: milk at end of feeding (yellow/creamy)
elements change:
- fat, carbs, proteins, cells
- osmolarity, pH
volume increases:
- 1st month: 22oz/day
- 6 months: 30oz/day
- 12 months: 25 oz/day
impact of maternal diet on breast milk
malnourished mothers have same proportions of macros as a nourished mother, but they produce less milk
water intake is important
-dehydrated mothers will decrease urine output before diminishing breastmilk output
fat intake influences lipid content
-not linked to infant health at this point
advantages of breast milk over infant formula
mother:
- convenient- always available at right temp
- free
- suckling causes uterine contraction–> oxytocin release; prevention of postpartum hemorrhage
- lactational amenorrhea decreases maternal Re loss
- more rapid return to postpartum weight loss
- decreased breast and ovarian cancer risks
- decrease osteoporosis risk
- improved CV outcomes
- bonding/stress reduction
- monetary savings (vs formula; decreased infant illnesses/hospitalizations)
- less expense per child on healthcare
- less missed days of work
infant:
- bonding
- benefits that can’t be duplicated (nutrients, immunology)
- immune support for immature immune system (macrophages, lymphocytes, antibodies/IgA, probiotics, lactoferrin)
- protection against infections (gastroenteritis, resp infections, acute otitis media)
- protection against (atopy, asthma, SIDS, diabetes, death, neurodevelopmental)
hospital practices that support and undermine successful breastfeeding
Support breastfeeding:
Baby Friendly Hospital Initiative:
- written breastfeeding policy
- train all hospital care staff
- inform all pregnant women of its benefits
- help mothers initiate breastfeeding w/in 30 min
- show mothers how to breastfeed
- only give infants breastmilk
- practice rooming-in
- encourage breastfeeding on demand
- no artificial pacifiers
- foster breastfeeding support groups
- breastfeeding in 1st hour
- skin/skin contact
- rooming in
- lactation consultants
- peer role modeling
- ad lib nursing/feeding
Inhibit successful breastfeeding:
- disruptive hospital practices
- inappropriate interruption/cessation of breast feeding
- availability and proportion of formula
- lack of training
- not encouraging breastfeeding as the norm
- separation of infant/mom
- mother discouraged BF/limited time suckling
- covert formula feeding
- D/C packs with formula
- lack of support
- pacifier use
published recommendations for infant feeding practices from delivery through 2 years of life
WHO:
- exclusive breastfeeding for 6 mo
- continue to at least 2 yrs
American Academy of Pediatrics:
- Exclusive breastfeeding for 6 mo
- continue to at least 1 yr
US Healthy People 2020 Goals:
- 82% ever breastfeed
- 61% at 6 mo
- 34% at 12 mo
- exclusive BF for 3 mo (46%)
- exclusive BF for 6 mo (25%)
- system level goals: increase worksite lactation support groups; decrease BF infants who receive formula supplementation within 1st 2 days of life; increase births in facilities that provide recommended care for BF mother/infants
AAP and WHO recommend infants be nursed skin/skin within the first hour after birth (before sleep)
- thermoregulation
- better BF outcomes at 4 mo
- breastfeeding crawl
newborn’s adaptation to extra-uterine life
first 3 days:
- colostrum (high fat, protein, Ig’s, low vol)
- practice breast feeding
- E source (12 hr store of glycogen; glucose drop –> gluconeogenesis; stress —> glycerol and fatty acids)
lactogenesis stage 2- occurs about 3-4 days after life- “milk comes in”
-subsequent milk production based on supply and demand
frequency of breast feeding:
- on demand
- variable time between feeds (30min-4 hrs)
- 8-12 times/day in beginning
- thorough emptying of breast is important (hind milk; also good for lactogenesis)
- duration varies (10-30min?)
early patterns of weight loss and regain by the infant
normal:
- infants expected to lose 5-7% of their birth weight
- typically stop losing weight by 5 days (breast milk comes in)
- start gaining 15-30g/day
- regain of Birth weight BW by 7-14 days
formula fed babies don’t go through the dip/regain
common issues:
- poor feeding/poor weight gain (requires immediate medical attention- dehydration/hypernatremia, jaundice)
- can lead to poor milk production
prevention:
- in-hosital observation of feeding/weight gain
- outpatient F/U (within 1-4 days)
WHO growth standards with the US/CDC growth references for infants through the age of 2
CDC growth charts:
difference in growth of breastfed vs formula fed infants:
-first 3 months similar weight gain
-after: formula-fed gains more weight
-12mo: formula fed 0.65kg more
-until 2010, growth charts were based on sample of formula-fed infants (Breastfed infants looked “growth faltering”)
recommend to use WHO growth charts in children 0-2yo:
- biggest differences (vs CDC) in growth after 6 months
- for high weights, earlier “overweight” (earlier recognition)
- for low weighs, less “underweight” (fewer dx’s of growth faltering)
characterize the terminal duct lobular unit
TDLU:
- functional unit in breast
- large duct differentiates into smaller ducts, eventually a terminal duct w/ small tubules/acini = terminal duct lobule unit
- the area where most changes occur
entire ductal system is lined by 2-cell layer:
- past the nipple squamous epithelium
- 2 cell layers must be present for normal histology
- luminal epithelial layer (functional milk production; single layer)
- myoepithelial cell layer (outer; contractile properties; supporting inner layer; absent in malignancies)
compare/contrast breast histology in different states: resting, pregnancy, lactation, postmenopausal involution
Resting:
- puberty: stimulation by E and P
- forms acini and terminal ducts
- 2nd half of menstruation: larger lobules and increased acini; involution at end of menses
Pregnancy:
- increase in acini
- entire lobule increases in size
- epi vacuolization–> produces secretions into lumen
Lactation:
- very little stroma left
- mostly lobules composed of back-to-back tubules
- involution after lactation 2-3 months
Postmenopausal Involution:
- Involuted TDLUs
- ductal system remains
- lobules become small/atrophic
- comparatively more stroma and less glandular tissue
- more fat and less fibrous tissue
Common congenital breast anomalies, incl supernumerary nipple/breasts, accessory breast tissue, and congenital inversion of nipples
Supernumerary nipple/breast:
- accessory breasts
- along milk line, present during fetal development
- most common site for ectopic breast tissue = axilla
- may feel lump in axilla during menses/pregnancy
- prophylactic mastectomies may leave some breast tissue behind
Accessory Breast tissue:
-additional breast tissues along milk line
Congenital Inversion of Nipples:
- can occur and correct itself over time
- some advanced breast cancers can also have retraction (from fibrosis retracting skin)
Key histologic characteristics of lesions: apocrine metaplasia blue-dome cysts sclerosing adenosis acute mastitis and abscess chronic mastitis mammary duct ecstasies plasma cell mastitis granulomatous mastitis fact necrosis of breast fibroadenoma lactating adenoma intraductal papilloma phyllodes tumor gynecomasti
apocrine metaplasia:
- cystic changes
- epithelial cells undergo change that makes them look like apocrine glands
- protruding appearance into lumen; AKA apocrine snouts
blue-dome cysts:
-non-proliferative fibrocystic change w/ epithelial cells undergoing apocrine metaplasia –> fluid-filled blue dome cysts
sclerosing adenosis:
- fibrous tissue and adenosis, but NO cyst formation
- micro: adenosis, marked fibrosis which may compress/distort the lumens of acini and ducts; giving the appearance of solid cords of cells
- myoepithelial cells are still present (vs cancer)
acute mastitis:
- occurs in young F during lactation
- swollen, red, painful breast (inflammatory)
- cracked or inflamed skin and milk stasis permits entry and proliferation of organisms (Staph, ex)
- acute inflammation- neutrophils
- acute abscess formation
- tx w/ antibiotics; surgical drainage of pus
- DDx: inflammatory carcinoma (malignant; not a true inflammation)
chronic mastitis:
- postmenopausal F
- duct obstruction by inspissated secretion or cell debris
- dilation of ducts (duct ectasia)
- stasis of secretion and epithelial debris
- can go on to plasma cell mastitis or granulomatous mastitis
- –> irregular fibrosis
- painless, irregular, fixed mass mimicking carcinoma (absence of signs of acute inflammation)
plasma cell mastitis:
- stasis of secretion and epithelial debris
- infiltration by lymphocytes and plasma cells
granulomatous mastitis:
- stasis of secretion and epithelial debris
- duct rupture w/ release of lipid contents
- infiltration by foamy histiocytes
Recurrent subareolar abscess AKA periductal mastitis:
- clinically appears like infection (abscess)
- related to smoking
- metaplastic change of luminal epithelium; and squamous epithelium continues deep into duct
- squamous cells tend to mature and fall off into lumen; induce inflammatory response and abscess formation
- can cause fistula w/ oozing pus on skin surface
- tx w/ surgical excision
fact necrosis of breast:
- benign
- necrosis of fatty tissue in stroma
- Hx of trauma or surgery, ischemia?
- ill-defined mass (Can mimic carcinoma)
- early phase: necrotic fat cells, neutrophils
- late phase: macrophages, giant cells, fibrosis, Calcifications, fibrous tissue
- clinicially and on mammogram very suspicious for cancer (irregular, calcified, hard mass)
fibroadenoma:
- most common benign neoplasm of breast
- discrete, capsulated mass 2-4cm
- firm and mobile, but not irregular
- arises from TDLU (made of stroma/fibrous and glandular tissue)
- can occur in any age group
- can be proliferative (Epithelial hyperplasia- >2 cell layers)
lactating adenoma:
- arises from TDLU (occurs in lactating F breasts), but mostly glandular proliferation
- mass is not as firm as fibroadenoma
- discrete, well-circumscribed, rounded mass
- can sometimes now rapidly
phyllodes tumor:
- can be benign, borderline, or malignant
- benign: “leaf life growth” into cystic spaces; mostly stroma proliferation
- large >4cm, pushing margin
- low grade: can recur
- high grade: can metastasize to lungs, bones
- atypical fibrobastic cells in stroma and a lot of mitoses = malignant phyllodes tumor
intraductal papilloma:
- occurs in larger ducts closer to nipple area
- ~1cm size
- proliferation of epithelium w/ finger-like processes –> dilation of duct
- delicate papillae, fibrovascular core, 2 cell epi layer
- bloody nipple discharge
- can become malignant
gynecomastia:
- M breast (common in young and elderly)
- assoc w/ changes in estrogen levels
- unilateral or bilateral
- can use FNA for biopsy
- increased ducts and fibrous stroma proliferation
- no lobules in M breast
differentiate between non-proliferative and proliferative fibrocystic changes
Fibrocystic change:
- fibrosis and cystic change; and sometimes proliferation of epithelium
- gross exam= cystic structures and white fibrosis
- can be multiple cysts or one large cyst filled w/ fluid arising from TDLU; and fibroplasia and epithelium increasing; may be a prominent lump or diffuse
- seen in 60-80% of autopsies
- asymptomatic, or pain/nodularity
- ranges from innocuous to pre-malignant
- due to hormonal changes of body
Non-proliferative fibrocystic change:
- cysts/fibrosis
- epithelial hyperplasia ABSENT
- some epithelial cells may undergo apocrine metaplasia –> blue domed cysts
- only 2 cell layers
Proliferative fibrocystic change:
- cysts/fibrosis
- epithelial hyperplasia
- lobular hyperplasia (acinar epithelium):
- –atypical lobular hyperplasia
- –LCIS
- ductal hyperplasia (terminal duct):
- –usual hyperplasia (mild, moderate, florid)
- –atypical ductal hyperplasia
- –DCIS
Sclerosing adenosis:
- fibrous tissue and adenosis, but no cyst formation (vs the other 2)
- gross: hard, rubbery, looks a lot like cancer
- micro: adenosis, marked fibrosis which may compress/distort the lumens of acini and ducts; giving the appearance of solid cords of cells
- myoepithelial cells are still present (vs cancer)
compare/contrast usual ductal hyperplasia and atypical ductal hyperplasia
Usual ductal hyperplasia:
- can be mild, moderate, or florid
- mild:
- –some heaping up of endothelial cells
- –more than 2 cell layers
- –focally involving the ducts
- –proliferative change associated w/ mild hyperplasia
- moderate:
- –more proliferation
- –some bridges of connected epithelial layers
- –lumen is at periphery w/ irregular slits
- florid:
- –duct is completely filled
- –very few luminal slits at periphery
- –cells overlap/crowd; cell bodies are not clear
Atypical ductal hyperplasia:
- proliferation of epithelium
- cell bodies are more visible- no overlapping
- luminal holes left behind, but more discrete and punched out (vs slits)
- assoc w/ higher risk of developing cancer
DCIS:
- more atypia
- mitoses
- may see necrosis within ducts
- basement membrane is intact
- myoepithelial layer is intact